Matches in SemOpenAlex for { <https://semopenalex.org/work/W2588751194> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- W2588751194 abstract "Background: The recurrence rate after soft tissue sarcoma (STS) treatment ranges between 20-25 % ,and usually occurs within 2-3 years after primary surgery. In Africa, many of the patients present late, access to adjuvant therapy is not guaranteed either. The basis of this study was to establish patterns and factors affecting recurrence and mortality after surgical treatment at a national referral medical facility. Methods: A five and a half years retrospective study between January 2003 and June 2007 and a six months prospective follow-up arm between July 2008 and March 2009. Data reviewed from all eligible surgically treated patients were demographic variables, duration of symptoms, anatomical distribution, investigations, adjuvant therapy, tumour type, size, grade and stage and surgical margins status. The outcome variables were tumour recurrence and death. Results: Mean age was 32.52+18.17 years. The male/female sex ratio was 0.97:1. The mean duration of symptoms was 10.87+18.75 months. The extremities had the most number of cases (62%). Fibrosarcoma was the most common histological type (36.0%) and the mean tumour size was 13.0 +7.36 cm. Most (44.7%) patients presented with high grade tumours and 78.0 % of the patients presented with a recurrence. Most of the recurrences (71.7%) occurred within the first year of treatment. Failure to get adjuvant therapy (p 5cm (p=0.02), advanced stage (III and IV) (p<0.001), and positive microscopic margins (p<0.001) were adverse prognostic factors for recurrence. Presentation with a recurrent tumour (p<0.027), failure to receive adjuvant therapy (p<0.001), advanced stages (III and IV) (p<0.001), positive microscopic margins (p<0.001), and high grade tumours (p<0.001), were predictors for death. Conclusions :Advanced stages of STS, higher histological grades, positive microscopic surgical margins, and failure to receive adjuvant treatment influenced both recurrence and mortality after surgical treatment. Better outcome results from surgical treatment of soft tissue sarcomas may be achieved if efforts to treat them earlier were to be a reality." @default.
- W2588751194 created "2017-02-24" @default.
- W2588751194 creator A5008398466 @default.
- W2588751194 creator A5023262509 @default.
- W2588751194 date "2013-01-01" @default.
- W2588751194 modified "2023-09-24" @default.
- W2588751194 title "Recurrence and Mortality after Surgical Treatment of Soft Tissue Sarcomas" @default.
- W2588751194 cites W1862666273 @default.
- W2588751194 cites W1967931026 @default.
- W2588751194 cites W1971975468 @default.
- W2588751194 cites W1984052284 @default.
- W2588751194 cites W1993867849 @default.
- W2588751194 cites W2020617188 @default.
- W2588751194 cites W2040120822 @default.
- W2588751194 cites W2088074688 @default.
- W2588751194 cites W2103211648 @default.
- W2588751194 cites W2112441719 @default.
- W2588751194 cites W2114774464 @default.
- W2588751194 cites W2118934037 @default.
- W2588751194 cites W2139973326 @default.
- W2588751194 cites W2172195143 @default.
- W2588751194 cites W2410428480 @default.
- W2588751194 cites W2551773592 @default.
- W2588751194 cites W267131885 @default.
- W2588751194 cites W330646370 @default.
- W2588751194 hasPublicationYear "2013" @default.
- W2588751194 type Work @default.
- W2588751194 sameAs 2588751194 @default.
- W2588751194 citedByCount "0" @default.
- W2588751194 crossrefType "journal-article" @default.
- W2588751194 hasAuthorship W2588751194A5008398466 @default.
- W2588751194 hasAuthorship W2588751194A5023262509 @default.
- W2588751194 hasConcept C136948725 @default.
- W2588751194 hasConcept C141071460 @default.
- W2588751194 hasConcept C142724271 @default.
- W2588751194 hasConcept C146357865 @default.
- W2588751194 hasConcept C151730666 @default.
- W2588751194 hasConcept C167135981 @default.
- W2588751194 hasConcept C195910791 @default.
- W2588751194 hasConcept C2776135927 @default.
- W2588751194 hasConcept C2776694085 @default.
- W2588751194 hasConcept C2777982462 @default.
- W2588751194 hasConcept C2778256501 @default.
- W2588751194 hasConcept C2778629024 @default.
- W2588751194 hasConcept C512399662 @default.
- W2588751194 hasConcept C71924100 @default.
- W2588751194 hasConcept C86803240 @default.
- W2588751194 hasConceptScore W2588751194C136948725 @default.
- W2588751194 hasConceptScore W2588751194C141071460 @default.
- W2588751194 hasConceptScore W2588751194C142724271 @default.
- W2588751194 hasConceptScore W2588751194C146357865 @default.
- W2588751194 hasConceptScore W2588751194C151730666 @default.
- W2588751194 hasConceptScore W2588751194C167135981 @default.
- W2588751194 hasConceptScore W2588751194C195910791 @default.
- W2588751194 hasConceptScore W2588751194C2776135927 @default.
- W2588751194 hasConceptScore W2588751194C2776694085 @default.
- W2588751194 hasConceptScore W2588751194C2777982462 @default.
- W2588751194 hasConceptScore W2588751194C2778256501 @default.
- W2588751194 hasConceptScore W2588751194C2778629024 @default.
- W2588751194 hasConceptScore W2588751194C512399662 @default.
- W2588751194 hasConceptScore W2588751194C71924100 @default.
- W2588751194 hasConceptScore W2588751194C86803240 @default.
- W2588751194 hasIssue "2" @default.
- W2588751194 hasLocation W25887511941 @default.
- W2588751194 hasOpenAccess W2588751194 @default.
- W2588751194 hasPrimaryLocation W25887511941 @default.
- W2588751194 hasVolume "10" @default.
- W2588751194 isParatext "false" @default.
- W2588751194 isRetracted "false" @default.
- W2588751194 magId "2588751194" @default.
- W2588751194 workType "article" @default.